Filing Details

Accession Number:
0001179110-12-017722
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-14 19:26:00
Reporting Period:
2012-12-12
Filing Date:
2012-12-14
Accepted Time:
2012-12-14 19:26:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Depomed Inc DEPO Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1367754 M Matthew Gosling 7999 Gateway Boulevard, Suite 300
Newark CA 94560
Senior Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-12 48,125 $3.09 65,702 No 4 M Direct
Common Stock Disposition 2012-12-12 65,702 $5.84 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2012-12-12 48,125 $0.00 48,125 $3.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,875 2020-01-17 No 4 M Direct
Footnotes
  1. 70,000 stock options were granted on 1/17/2010 and exercisable in 48 equal monthly installments.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.7901 to $5.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
  3. The shares reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2012.